Functional and molecular characterization of glioblastoma multiforme-derived cancer stem cells

Journal of B.U.ON.

Volumn 15, Issue 3, 2010, Pages 583-591

  Tomuleasa, Ciprian ^a,c   Soritau, O ^a   Rus Ciuca, D ^b,c   Ioani, H ^b   Susman, S ^b,c   Petrescu, M ^b   Timis, T ^c   Cernea, D ^a   Kacso, G ^a,c   Irimie, A ^a,c   Florian, I S ^b,c  

^a Ion Chiricuta Comprehensive Cancer Center   (Romania)

^b Emergency University Clinical Hospital   (Romania)

^c IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Brain cancer stem cells; High grade gliomas; In vitro characterization

Indexed keywords

CD133 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; ENDOGLIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; NESTIN; NEUROFILAMENT PROTEIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG;

ADULT; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CASE REPORT; CELL CULTURE; CELL PROLIFERATION; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NEURAL STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SPHEROID;

BRAIN NEOPLASMS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3;

EID: 77957737616     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Louis DN, Ohgaki H, Wiestler OD et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109. (Pubitemid 47103521)
2. Figarella-Branger D, Colin C, Coulibaly B et al. Classification histologique et moléculaire des gliomes. Rev Neurol (Paris) 2008; 164: 505-515.
3. Kislin KL, McDonough WS, Eschbacher JM, Armstrong BA, Berens ME. NHERF-1: modulator of glioblastoma cell migration and invasion. Neoplasia 2009; 11: 337-387.
4. Godlewski J, Newton HB, Chiocca EA, Lawler SE. MicroRNAs and glioblastoma. Cell Death Differ 2009; June 12; [Epub ahead of print].
5. Begin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet 2003; 361: 323-331.
6. Oka N, Soeda A, Noda S, Iwama T. Brain tumor stem cells from an adenoid glioblastoma multiforme. Neurol Med Chir (Tokyo) 2009; 49: 146-151.
7. Pochampally R. Colony forming unit assays for MSCs. Methods Mol Biol 2008; 449: 83-91.
8. Tomuleasa CI, Foris V, Soritau O et al. Effects of 60Co gamma-rays on human osteoprogenitor cells. Rom J Morphol Embryol 2009; 50: 349-355.
9. Donnenberg VS, Meyer EM, Donnenberg AD. Measurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cells. In: Yu JS (Ed): Cancer Stem Cells. Methods and Protocols. Los Angeles: Springer, 2009, pp 261-281.
10. Stupp R, Mason WB, van der Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-996.
11. Giese A, Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996; 39: 235-252. (Pubitemid 26251544)
12. Claes A, Idema AJ, Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol 2007; 114: 443-458. (Pubitemid 47521501)
13. Nakada M, Nakada S, Demuth T et al. Molecular targets of glioma invasion. Cell Mol Life Sci 2007; 64: 458-478.
14. Salhia B, Tran NL, Symons M et al. Molecular pathways triggering glioma cell invasion. Expert Rev Mol Diagn 2006; 6: 613-626. (Pubitemid 44179946)
15. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med 2005; 353: 811-822.
16. Glantz M, Kesari S, Recht L, Fleischhack G, van Horn A. Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay. Semin Oncol 2009; 36 (Suppl 2): S17-S24.
17. Widera D, Kaus A, Kaltschmidt C et al. Neural stem cells, inflammation and NF-kB: basic principle of maintenance and repair or origin of brain tumors? J Cell Mol Med 2008; 12: 459-470.
18. Abounader R, Laterra J. Scatter factor/hepatocyte growth factor in brain tumour growth and angiogenesis. NeuroOncol 2005; 7: 436-451. (Pubitemid 41555616)
19. Song SW, Fuller GN, Khan A et al. Ilp45, an insulin-like growth factor binding protein 2 (IGFBP-2) antagonizes IGFBP-2 stimulation of glioma cell invasion. Proc Natl Sci USA 2003; 100: 13970-13975.
20. Drappatz J, Norden AD, Wen PY. Therapeutic strategies for inhibiting invasion in glioblastoma. Expert Rev Neurother 2009; 9: 519-534.
21. Bao S, Wu Q, McLendon RE et al. Glioma stem cells promote radioresistance by preferential activation of DNA damage response. Nature 2006; 444: 756-760. (Pubitemid 44949604)
22. Wakimoto H, Kesari S, Farrell CJ et al. Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res 2009; 69: 3472-3481.
23. Diaz Miqueli A, Rolff J, Lemm M, Fichtner I, Perez R, Montera E. Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies. Br J Cancer 2009; 100: 950-958.
24. Lefranc F, Mijatović T, Kiss R. La pompe à sodium pourrait représenter une nouvelle cible pour le traitement des glioblastomes. Bull Cancer 2008; 95: 1-11. (Pubitemid 351528764)
25. Rudin CM, Hann CL, Laterra J et al. Treatment of medullo-blastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009; 361: 1173-1178.